文献速递肝病

质子泵抑制剂治疗对自发性细菌性腹膜炎病原谱的影响

Altered Pathogen Spectrum of Spontaneous Bacterial Peritonitis in Patients Treated With Proton Pump Inhibitors.
PubMed 文献 · Aliment Pharmacol Ther · 2026-02-17

本研究纳入德国两家三级中心227例培养阳性的肝硬化自发性细菌性腹膜炎(SBP)患者,分析PPI治疗与SBP病原谱的关系。结果显示PPI组革兰阳性菌显著更多(62.1% vs 34.0%,p<0.001),尤以肠球菌属、链球菌属和金黄色葡萄球菌增加为主;非PPI组革兰阴性菌更多(64.0% vs 40.7%,p=0.003)。多变量分析中PPI使用是革兰阳性SBP的独立预测因素(OR 2.719,95%CI 1.343-5.506,p=0.005)。

要点

  • PPI组SBP中革兰阳性菌占比显著高于非PPI组(62.1% vs 34.0%)。
  • PPI使用是革兰阳性SBP的独立预测因素(OR 2.719)。
  • PPI组肠球菌属增多,过半仅对扩展革兰阳性活性抗生素敏感。

核心结论

  • PPI治疗与培养阳性SBP中革兰阳性病原体(包括肠球菌属)丰度增加相关,可指导SBP经验性抗生素治疗。

研究设计与样本

  • 回顾性分析德国两家三级中心227例培养阳性的肝硬化SBP患者,按PPI治疗分组比较病原谱。

主要发现

  • PPI组革兰阳性菌显著多于非PPI组(62.1% vs 34.0%,p<0.001)。
  • PPI组肠球菌属(22.0% vs 8.0%)、链球菌属(14.7% vs 6.0%)和金黄色葡萄球菌(15.8% vs 8.0%)丰度增加。
  • 超过一半的肠球菌分离株仅对具有扩展革兰阳性活性的抗生素敏感。
  • 非PPI组革兰阴性菌显著更多(64.0% vs 40.7%,p=0.003),主要因大肠埃希菌更常见(40.0% vs 20.3%)。
  • 多变量logistic回归中PPI使用是革兰阳性SBP的独立预测因素(OR 2.719,95%CI 1.343-5.506,p=0.005),校正医院获得性感染(OR 2.609,95%CI 1.464-4.650,p=0.001)和Child-Pugh评分(OR 0.684,95%CI 0.552-0.848,p<0.001)。

临床怎么用

  • 对正在使用PPI的肝硬化SBP患者,经验性抗生素选择应覆盖革兰阳性菌,包括肠球菌属。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Proton pump inhibitor (PPI) treatment leads to significant changes in the gut microbiota composition. We hypothesized that these alterations may transfer into distinct changes in the causative agents of spontaneous bacterial peritonitis (SBP) in patients with cirrhosis. AIMS: To investigate the impact of PPI treatment on the pathogen spectrum of SBP. METHODS: A total of 227 cirrhosis patients with culture-positive SBP from two German tertiary care centers were included and the pathogen spectrum of SBP was analysed with respect to PPI treatment. RESULTS: In the PPI-group, gram-positive bacteria were significantly more common compared to the non-PPI-group (62.1% vs. 34.0%, p < 0.001). This involved increased abundances of Enterococcus spp. (22.0% vs. 8.0%), Streptococcus spp. (14.7% vs. 6.0%) and Staphylococcus aureus (15.8% vs. 8.0%). Importantly, more than half of the Enterococcus isolates were susceptible only to antibiotics with extended gram-positive activity. Conversely, gram-negative bacteria were significantly more frequent in the non-PPI-group compared to the PPI-group (64.0% vs. 40.7%, p = 0.003), primarily due to a higher prevalence of E. coli (40.0% vs. 20.3%). In uni- and multivariable logistic regression analyses, PPI use was an independent predictor of gram-positive SBP (OR 2.719, 95% CI 1.343-5.506, p = 0.005), adjusted for nosocomial infection (OR 2.609, 95% CI 1.464-4.650, p = 0.001) and Child-Pugh score (OR 0.684, 0.552-0.848, p < 0.001). CONCLUSIONS: PPI treatment is associated with increased abundances of gram-positive pathogens, including Enterococcus spp., in culture-positive SBP. This result can help guide empiric antibiotic therapy of SBP.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Kitchen P, Schütte SL, Tergast TL, et al. Altered Pathogen Spectrum of Spontaneous Bacterial Peritonitis in Patients Treated With Proton Pump Inhibitors. Aliment Pharmacol Ther. 2026. PMID: 41704052. doi:10.1111/apt.70593

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。